Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Medical Crossfire: How Do Recent Pathophysiological Findings in Pustular Psoriasis Have the Potential to Shape a New Treatment Paradigm?

Release Date: July 28, 2020
Expiration Date: July 28, 2021

Activity Overview

The Medical Crossfire®, one of PER’s signature educational formats, is a video-based program in which a panel of distinguished experts engage in spirited discussions and debates on a particular clinical topic. In this activity, 4 key thought leaders explore the types and features of pustular psoriasis with a focus on the pathophysiological findings that have led to emerging treatments for the management of this devastating skin condition. This engaging discussion will help place new developments into clinical context for clinicians to optimize care of patients with pustular psoriasis.

Acknowledgement of Support

This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

These activities are intended for attendees of the 2020 AAD Annual Meeting, including dermatologists, Primary Care Physicians, NPs, and PAs involved in the care and treatment of patients with pustular psoriasis.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Identify different types of pustular psoriasis based on symptom recognition, location, and accurate assessment of disease severity
  • Discuss recent pathophysiological findings in pustular psoriasis to differentiate from plaque psoriasis
  • Demonstrate increased knowledge of clinical data on emerging biologic therapies targeting the inflammatory pathway for treatment of pustular psoriasis

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Alan Menter, MD
Alan Menter, MD
Texas Dermatology Associates, Menter Dermatology Research Institute / Menter Cosmetic Institute
Director, Dermatology Residency Program
Baylor University Medical Center
Dallas, TX

Disclosures: Alan Menter, MD has no relevant financial relationships with commercial interests.

Lakshi Aldredge, MSN, ANP-BC, DCNP
Lakshi Aldredge, MSN, ANP-BC, DCNP
Adult Nurse Practitioner
VA Portland Healthcare System
Portland, OR

Disclosures: Consultant: AbbVie, Sun Pharma, Lilly, Sanofi Genzyme, Regeneron; Speaker’s Bureau: AbbVie, Sun Pharma, Lilly, Sanofi Genzyme, Regeneron.

Mark Lebwohl, MD
Mark Lebwohl, MD
Waldman Chair of Dermatology
Professor and System Chair, Dermatology
Icahn School of Medicine
Mount Sinai
New York, NY

Disclosures: Grant/Research: Abbvie, Amgen, Arcutis, Boehringer Ingelheim, Dermavant Sciences, Eli Lilly, Incyte, Janssen Research & Development, LLC, Leo Pharmaceuticals, Orth Dematologics, Pfizer, UCB, Inc.; Consultant: Aditum Bio, Allergan, Almirall, Arcutis, Inc., Avotres Therapeutics, BirchBioMed Inc., BMD Skincare, Inc., Boehringer-Ingelheim, Bristol-Myers Squibb, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant Sciences, EMD Serono, Evelo Biosciences, Facilitation of International Dermatology Education, Foundation for Research and Education in Dermatology, Inozyme Pharma, LEO Pharma, Meiji Seika Pharma, Menlo, Mitsubishi, Neuroderm, Pfizer, Promius/Dr. Reddy’s Laboratories, Theravance, and Verrica.

Abby S. Van Voorhees, MD
Abby S. Van Voorhees, MD
Professor and Chair, Dermatology
Eastern Virginia Medical School
Norfolk, VA

Disclosures: Grant/Research: Abbvie, Celgene, Lilly; Consultant: Dermtech, WebMD, Celgene, UCB, Novartis, Lilly, AbbVie.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By